FI
PFE icon

Focused Investors’s Pfizer PFE Stock Holding History

Focused Investors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2,066,051
Closed -$60M – 23
2013
Q4 		$60M Sell
2,066,051
-22,977
-1% -$669K 2.36% 23
2013
Q3 		$56.9M Sell
2,089,028
-412,325
-16% -$11.2M 2.45% 22
2013
Q2 		$66.5M Buy
+2,501,353
New +$69.1M 2.89% 20

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Focused Investors's PFE Position: Q1 2014 in Review

Focused Investors sold out of Pfizer (PFE) in Q1 2014, closing a stake of 2,066,051 shares — an estimated $60M sold.

Focused Investors first reported a position in PFE in Q2 2013 and held it in 3 quarters. The position peaked at $66.5M in Q2 2013. 1,780 funds tracked by Wall St. Rank hold PFE as of Q1 2014.

  • Focused Investors reported no remaining Pfizer position as of Q1 2014 after selling out during the quarter.
  • Focused Investors sold 2,066,051 Pfizer shares in Q1 2014, an estimated $60M.
  • Focused Investors first reported a position in Pfizer in Q2 2013 and held it in 3 quarters.
  • Focused Investors's Pfizer position peaked at $66.5M in Q2 2013.
  • 1,780 funds tracked by Wall St. Rank held Pfizer as of Q1 2014.

Based on Focused Investors's 13F filing for Q1 2014, filed 2 May 2014.